Delivery Order SPE2DB20D9129-SPE2DB21FC5MD
- Not listed
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order (SPE2DB21FY22L) issued by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999. The IDC, which is valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $1,181.86 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The contract provides for the delivery of a variety of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for a Firm Fixed Price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) worth up to $499,999,999. Through this IDC, the DLA can issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $11,849.81 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical items, including both common and...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $18,526.83 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The contract, which runs through December 31, 2025, is for the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. The...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract covers a wide range of pharmaceutical products, including common medications as well as specialized drugs and medical supplies, to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers the provision of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health...
- SPE2DB20D9129Indefinite Delivery Contract
- SPE2DB20D9129-SPE2DB21FC5MDDelivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including both common and specialized medications, to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. This specific delivery order, valued at $2,161.50, is for pharmaceutical products and supplies to support the Prime Vendor Pharmaceutical Branch in Philadelphia. The contract has no set-aside designation. Through this and other federal contracts, DMS Pharmaceutical Group provides a wide array of pharmaceutical products and medical consumables to the DoD and Department of Veterans Affairs, solidifying its position as a critical supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/8/21 |